4.7 Editorial Material

Higher Drug Exposure During the First 24 Weeks of Ustekinumab Treatment Is Associated With Endoscopic Remission in Crohn's Disease

Journal

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Volume 21, Issue 3, Pages 838-+

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cgh.2021.12.020

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available